| PERIOD ENDING | 1-Jan-09 | 27-Dec-07 | | Total Revenue | 369,500 | 331,900 | | Cost of Revenue | 18,700 |
-
| | | Gross Profit | 350,800 | 331,900 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 165,200 | 166,900 | | Non Recurring | 11,500 | 1,900 | | Others | 12,400 | 5,700 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 173,200 | 157,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (25,200) |
-
| | Earnings Before Interest And Taxes | 136,500 | 157,400 | | Interest Expense | 51,800 | 57,300 | | Income Before Tax | 84,700 | 100,100 | | Income Tax Expense | 35,000 | 41,900 | | Minority Interest | (48,700) | (37,600) | | | | Net Income From Continuing Ops | 1,000 | 20,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 1,000 | 20,600 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $1,000 | $20,600 |
|
0.22% Nasdaq 
Income Statement
